Skip to content

Clinical trials

Inflammation trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Country / region: Australia Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20104
20113
20132
20141
20161
20171
20184
20193
20202
20213
20224
20233
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting5
Terminated4
Active, not recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Adelaide6
Amgen5
Inmune Bio, Inc.3
Xalud Therapeutics, Inc.3
AstraZeneca2
Garvan Institute of Medical Research2
Monash Medical Centre2
Peter MacCallum Cancer Centre, Australia2
Atara Biotherapeutics1
Bayside Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation40
Insulin Resistance6
Obesity5
Diabetes Mellitus, Type 24
Alzheimer Disease3
Arthritis3
Arthritis, Psoriatic3
Crohn Disease3
Dementia3
Osteoarthritis, Knee3

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.